Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Klinische Padiatrie|January 18, 2014
Cystic fibrosis as a rare cause of apple peel syndromeI J Broekaert, S van Koningsbruggen-Rietschel, E RietschelThe Journal of Antimicrobial Chemotherapy|February 4, 2014
Prevalence and molecular characterization of azole resistance in Aspergillus spp. isolates from German cystic fibrosis patientsJ Fischer, S van Koningsbruggen-Rietschel, E Rietschel, et al.The Journal of Antimicrobial Chemotherapy|December 3, 2015
Pharmacokinetics and safety of an 8 week continuous treatment with once-daily versus twice-daily inhalation of tobramycin in cystic fibrosis patientsS van Koningsbruggen-Rietschel, H E Heuer, N Merkel, et al.BMC Pulmonary Medicine|May 7, 2022
The effect of TGF-β1 polymorphisms on pulmonary disease progression in patients with cystic fibrosisT Trojan, Miguel A Alejandre Alcazar, G Fink, et al.Inflammation and Regeneration|October 25, 2023
CXCL10 deficiency limits macrophage infiltration, preserves lung matrix, and enables lung growth in bronchopulmonary dysplasiaDharmesh V Hirani, Florian Thielen, Siavash Mansouri, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 22, 2024
ECFS standards of care on CFTR-related disorders: Towards a comprehensive program for affected individualsE De Wachter, K De Boeck, I Sermet-Gaudelus, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 12, 2020
Building global development strategies for cf therapeutics during a transitional cftr modulator eraN Mayer-Hamblett, S van Koningsbruggen-Rietschel, D P Nichols, et al.Pneumologie (Stuttgart, Germany)|May 15, 2018
[CF Lung Disease - a German S3 Guideline: Module 2: Diagnostics and Treatment in Chronic Infection with Pseudomonas aeruginosa]C Schwarz, B Schulte-Hubbert, J Bend, et al.Pageof 1